CRISPR gene editing tech lead to new insights about hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is the most common of all genetic heart diseases and is the leading cause of sudden cardiac death. It is characterized by an abnormal thickening of the heart muscle, which over time can lead to cardiac dysfunction and, ultimately, heart failure.

from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/08/210812161848.htm
CRISPR gene editing tech lead to new insights about hypertrophic cardiomyopathy CRISPR gene editing tech lead to new insights about hypertrophic cardiomyopathy Reviewed by cmakigo on August 13, 2021 Rating: 5

No comments:

'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();
Powered by Blogger.